Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

High-salary medical specialists are in higher demand than primary care physicians

More hospitals and healthcare providers are seeking medical specialists compared to primary care physicians––and many of these roles comes with the highest starting salaries in the industry.

Thumbnail

Trump preparing another exec order on drug prices

President Trump is preparing to issue an executive order that would declare a favored nations clause for drug prices, ensuring the U.S. would not pay higher prices than other countries for prescription medications, CNBC reported.

Thumbnail

Medical AI top of mind for physicians planning careers

Most physicians rightly laugh off talk of their profession’s coming demise at the hands of AI. But more than a few are taking the blossoming technology into account when making career decisions.

Thumbnail

Obamacare lawsuit heads to appeals court

The biggest challenge to the Affordable Care Act to date heads to the 5th U.S. Circuit Court of Appeals in New Orleans Tuesday, July 9, for scheduled oral arguments in the case.

Thumbnail

Trump rule to disclose drug prices blocked by judge

A federal judge has blocked the Trump administration’s rule requiring drugmakers to publish the list prices of prescription medications in direct-to-consumer television advertisements.

Thumbnail

Cost of cancer deaths tops $94B annually

The economic cost of the of lost earnings due to cancer deaths in the U.S. was more than $94 billion in 2015, according to a new study published in JAMA Oncology.

Thumbnail

Medicare for all could mean a big payment cut

While general support for a universal healthcare system remains at about 50% among the public, the impact to the healthcare industry is being weighed––and providers could see huge payment cuts under certain policies. 

Thumbnail

Doctors aren’t using tools to keep drug costs down

Patients are worried about the rising cost of prescription drugs, and the high rate of cost growth has led lawmakers and the Trump administration to review steps to reduce runaway price growth. However, there are some ways for doctors to help patients avoid sticker shock on their prescriptions––and not many are using these tools, according to a report from NPR.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.